12/4
04:48 pm
oabi
OmniAb to Hold OmniUltra Virtual Investor Event on December 15 [Yahoo! Finance]
Low
Report
OmniAb to Hold OmniUltra Virtual Investor Event on December 15 [Yahoo! Finance]
12/4
04:05 pm
oabi
OmniAb to Hold OmniUltra Virtual Investor Event on December 15
Low
Report
OmniAb to Hold OmniUltra Virtual Investor Event on December 15
11/18
01:18 pm
oabi
OmniAb (NASDAQ:OABI) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
OmniAb (NASDAQ:OABI) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/17
06:00 pm
oabi
OmniAb Enters into a Technology License and Services Agreement for Antibody Discovery with a Newly-Formed Incubated Company of ArrowMark Partners and Viking Global Investors [Yahoo! Finance]
Medium
Report
OmniAb Enters into a Technology License and Services Agreement for Antibody Discovery with a Newly-Formed Incubated Company of ArrowMark Partners and Viking Global Investors [Yahoo! Finance]
11/17
05:23 pm
oabi
OmniAb Enters into a Technology License and Services Agreement for Antibody Discovery with a Newly-Formed Incubated Company of ArrowMark Partners and Viking Global Investors
Medium
Report
OmniAb Enters into a Technology License and Services Agreement for Antibody Discovery with a Newly-Formed Incubated Company of ArrowMark Partners and Viking Global Investors
11/12
01:28 pm
oabi
OmniAb (NASDAQ:OABI) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
OmniAb (NASDAQ:OABI) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/8
08:56 am
oabi
Analysts Have Been Trimming Their OmniAb, Inc. (NASDAQ:OABI) Price Target After Its Latest Report [Yahoo! Finance]
Medium
Report
Analysts Have Been Trimming Their OmniAb, Inc. (NASDAQ:OABI) Price Target After Its Latest Report [Yahoo! Finance]
11/6
12:10 am
oabi
OmniAb (OABI): Rapid 30.4% Revenue Growth Forecast Raises Questions for Loss-Weary Investors [Yahoo! Finance]
Medium
Report
OmniAb (OABI): Rapid 30.4% Revenue Growth Forecast Raises Questions for Loss-Weary Investors [Yahoo! Finance]
11/4
04:05 pm
oabi
OmniAb Reports Third Quarter 2025 Financial Results and Business Highlights
Low
Report
OmniAb Reports Third Quarter 2025 Financial Results and Business Highlights
10/16
08:00 am
oabi
OmniAb to Participate in Three Investor Conferences in November
Low
Report
OmniAb to Participate in Three Investor Conferences in November
10/14
08:00 am
oabi
OmniAb to Report Third Quarter 2025 Financial Results on November 4
Low
Report
OmniAb to Report Third Quarter 2025 Financial Results on November 4
9/22
12:01 pm
oabi
Angelini Pharma Signs Exclusive Option Agreement With Sovargen To License Global Development and Commercialization Rights For Innovative Brain Health Asset [Yahoo! Finance]
Low
Report
Angelini Pharma Signs Exclusive Option Agreement With Sovargen To License Global Development and Commercialization Rights For Innovative Brain Health Asset [Yahoo! Finance]